LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A successful case of dupilumab treatment for severe uremic pruritus

Photo from wikipedia

IL: interleukin NBUVB: narrow-band ultraviolet B phototherapy UP: uremic pruritus U remic pruritus (UP) is highly burdensome and difficult to treat. Previous studies implicated interleukin (IL)-31 in the pathogenesis of… Click to show full abstract

IL: interleukin NBUVB: narrow-band ultraviolet B phototherapy UP: uremic pruritus U remic pruritus (UP) is highly burdensome and difficult to treat. Previous studies implicated interleukin (IL)-31 in the pathogenesis of UP. IL-31 expression is upregulated by T-helper 2 cells in several pruritic disorders, including atopic dermatitis and cutaneous T-cell lymphoma. Yet, the role of T-helper 2 or other cytokines in UP has not been fully elucidated. We present a case of UP successfully treated with dupilumab, a fully human monoclonal antibody that targets IL-4 receptor a and blocks signaling of IL-4 and IL-13.

Keywords: case dupilumab; pruritus; case; uremic pruritus; successful case

Journal Title: JAAD Case Reports
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.